Measurement Of The Alpha 1-Proteinase Inhibitor (Alpha 1-Antitrypsin) Of Common Marmoset And Intestinal Protein Loss In Wasting Syndrome

Although wasting marmoset syndrome (WMS) is one of the biggest problems facing captive marmoset colonies, the mechanisms underlying its pathogenesis remain unclear. In our clinical experience, it is difficult to cure WMS-affected marmosets with severe hypoalbuminemia. Thus, the mechanisms underlying hypoalbuminemia in WMS must be understood. In the present study, we investigated whether intestinal protein loss, a known reason for hypoalbuminemia, occurs in this disease. Fecal a1-proteinase inhibitor (alpha 1-PI, also known as alpha 1-antitrypsin) has been used to diagnose intestinal protein loss in other species. To develop an assay system for this protein, marmoset alpha 1-PI was purified from plasma and antibodies against it were developed using the purified protein. Using the antibodies, a sandwich enzyme-linked immunosorbent assay (ELISA) to measure marmoset alpha 1-PI was developed, and its detection sensitivity for fecal samples was similar to 20-fold higher than that of a commercial kit for human alpha 1-PI. From this ELISA, the reference intervals for serum and feces of healthy marmosets were 0.87-1.85 mg/ml and 0.53-395.58 mu g/g, respectively. The average concentrations of alpha 1-PI in serum and feces of seven WMS-affected marmosets were 1.17 mg/ml and 1357.58 mu g/g, respectively. Although there were no significant differences in the serum concentrations between healthy and WMS-affected marmosets, the fecal concentrations were significantly higher in WMS-affected marmosets than in healthy individuals, suggesting that intestinal protein loss occurs in WMS. Intestinal protein loss of WMS-affected marmosets was significantly attenuated with treatment, suggesting that it is one of the mechanisms involved in the hypoalbuminemia observed in WMS.